Literature DB >> 17110828

Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use.

David A Smelson, Sandra L Tunis, Allen W Nyhuis, Douglas E Faries, Bruce J Kinon, Haya Ascher-Svanum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17110828     DOI: 10.1097/01.jcp.0000245562.99036.92

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  Pharmacological treatment of schizophrenia and co-occurring substance use disorders.

Authors:  David A Smelson; Lisa Dixon; Thomas Craig; Stephen Remolina; Steven L Batki; Noosha Niv; Richard Owen
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

2.  Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness.

Authors:  Oladunni Oluwoye; Jordan Skalisky; Ekaterina Burduli; Naomi S Chaytor; Sterling McPherson; Sean M Murphy; Jalene Herron; Katherine Hirchak; Mason Burley; Richard K Ries; John M Roll; Michael G McDonell
Journal:  Contemp Clin Trials       Date:  2018-04-20       Impact factor: 2.226

3.  Predictors of switching antipsychotic medications in the treatment of schizophrenia.

Authors:  Allen W Nyhuis; Douglas E Faries; Haya Ascher-Svanum; Virginia L Stauffer; Bruce J Kinon
Journal:  BMC Psychiatry       Date:  2010-09-28       Impact factor: 3.630

Review 4.  Treatment of patients comorbid for addiction and other psychiatric disorders.

Authors:  Kathleen T Brady; Marcia L Verduin; Bryan K Tolliver
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

Review 5.  Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.

Authors:  Henk S Temmingh; Taryn Williams; Nandi Siegfried; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2018-01-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.